Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laurel Stokely"'
Autor:
Frank Cichocki, Martin Felices, Svetlana Gaidarova, Ryan Bjordahl, Bahram Valamehr, David Robbins, Laurel Stokely, Jeffrey S. Miller, Betsy Rezner, Hongbo Wang, Bruce R. Blazar, Moyar Q. Ge, Raedun Clarke, Ramzey Abujarour, Laura Bendzick, Megan Robinson, Tom Tong Lee, Zachary Davis, Paul Rogers, Dan S. Kaufman, Katie Tuininga, Sajid Mahmood
Publikováno v:
Science translational medicine, vol 12, iss 568
Sci Transl Med
Sci Transl Med
The development of immunotherapeutic monoclonal antibodies targeting checkpoint inhibitory receptors, such as programmed cell death 1 (PD-1), or their ligands, such as PD-L1, has transformed the oncology landscape. However, durable tumor regression i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e726ff274f3666a5b1b2356c5862ef50
https://escholarship.org/uc/item/6s79g6hx
https://escholarship.org/uc/item/6s79g6hx
Autor:
Ramzey Abujarour, Cheng-Jang Wu, Jason ORourke, Mandal Mili, Bahram Valamehr, Jolanta Stefanski, Gloria Hsia, Alec Witty, Bi-Huei Yang, Sjoukje J. C. van der Stegen, Gilberto Hernandez, Michel Sadelain, Mochtar Pribadi, Chia-Wei Chang, Helen Chu, Yi-Shin Lai, Raedun Clarke, Thomas H. Lee, Meilan Wu, Juan Zhen, Isabelle Riviere, Mushtaq Husain, Laurel Stokely, Chad Dufaud, Helena Shaked, Alma Gutierrez
Publikováno v:
Cancer Research. 80:3245-3245
Genetic engineering of T cells using a chimeric antigen receptor targeting CD19 antigen (CAR19) is now a well-established treatment of B cell malignancies. While cellular immunotherapies are entering front line treatment, substantial limitations curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b887f3dfdacd0fd61ab763cf4f11c2f
https://doi.org/10.1158/1538-7445.am2020-3245
https://doi.org/10.1158/1538-7445.am2020-3245
Autor:
Mochtar Pribadi, Bahram Valamehr, Michel Sadelain, Alec Witty, Ramzey Abujarour, Hui-yi Chu, Helena Shaked, Mandal Mili, Jason ORourke, Brian Groff, Laurel Stokely, Mushtaq Husain, Alma Gutierrez, Yi-Shin Lai, Chia-Wei Chang, Raedun Clarke, Isabelle Riviere, Thomas H. Lee, Bi-Huei Yang, Sjoukje J. C. van der Stegen, Pieter Lindenbergh
Publikováno v:
Blood. 134:4434-4434
Long-term follow-up of adoptive transfer of autologous T cells expressing a chimeric antigen receptor (CAR) directed to CD19 antigen has demonstrated encouraging, durable clinical outcome in various B cell malignancies. However, to make such CAR-T ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::442fa897502c18a6ee9749a5817bb784
https://doi.org/10.1182/blood-2019-130584
https://doi.org/10.1182/blood-2019-130584
Autor:
Yi-Shin Lai, Eigen Peralta, Bahram Valamehr, Mochtar Pribadi, Justin Eyquem, Judith Feucht, Ramzey Abujarour, Jason Dinella, Helen Chu, Mushtaq Husain, Chris Truong, Michel Sadelain, Laurel Stokely, Jorge Mansilla-Soto, Mohsen Sabouri-Ghomi, Chia-Wei Chang, Sjoukje J. C. van der Stegen, Thomas H. Lee, Raedun Clarke, Isabelle Riviere, Miguel Meza
Publikováno v:
Blood. 132:4546-4546
The advent of off-the-shelf chimeric antigen receptor (CAR) T cell therapeutics is widely recognized to be a major potential advancement for the treatment of cancer. Several obstacles currently hamper the broad use of CAR T cells, including the inher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7490e0cccc2f3fc6eafb23e9e788dff9
https://doi.org/10.1182/blood-2018-99-116843
https://doi.org/10.1182/blood-2018-99-116843
Autor:
Moyar Q. Ge, Svetlana Gaidarova, Sajid Mahmood, Laurel Stokely, Ryan Bjordahl, Raedun Clarke, Paul Rogers, Megan Robinson, Bahram Valamehr, Ramzey Abujarour, Tom Tong Lee, Betsy Rezner
Publikováno v:
Cancer Research. 78:3576-3576
The development of PD1/PDL1 targeting checkpoint inhibitors (CI) has transformed the oncology landscape, providing long term remissions in multiple indications. However, many tumor subtypes are resistant to checkpoint blockade therapy, and relapse re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9a5c68ee1aab9b4082d2c3d7328dcd8
https://doi.org/10.1158/1538-7445.am2018-3576
https://doi.org/10.1158/1538-7445.am2018-3576